Endocrine-disrupting chemicals and public health protection: A statement of principles from the Endocrine Society

Endocrinology

Volumn 153, Issue 9, 2012, Pages 4097-4110

  Thomas Zoeller, R ^a   Brown, T R ^b   Doan, L L ^c   Gore, A C ^d   Skakkebaek, N E ^e   Soto, A M ^f   Woodruff, T J ^g   Vom Saal, F S ^h  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Harvard Medical School   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e Rigshospitalet   (Denmark)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN; ANDROGEN RECEPTOR; DIETHYLSTILBESTROL; DIOXIN; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR; TESTOSTERONE; THYROTROPIN; THYROXINE;

ARTICLE; DEVELOPMENTAL STAGE; HUMAN; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; RECEPTOR BINDING; RISK ASSESSMENT; SCREENING; STEROIDOGENESIS; THYROID GLAND;

ENDOCRINE DISRUPTORS; HUMANS; PUBLIC HEALTH; SOCIETIES, MEDICAL;

EID: 84865432029     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1422     Document Type: Article

References (73)

1. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC 2009 Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30:293-342
2. Eldridge JC, Laws SC 2010 The U.S. EPA's Tier 1 screening battery for endocrine disruptor compounds. New York: Informa Healthcare USA, Inc
3. (EDSTAC)USEPA EDSaTAC 1998 Endocrine disrupter screening and testing advisory committee final report. Washington, DC: United States Government. http://www.epa.gov/scipoly/oscpendo/history/finalrpt.htm
4. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, Miller R, Moore J, Rolland R, Scott G, Sheehan DM, Sinks T, Tilson HA 1996 Research needs for the risk assessment of health and environmental effect of endocrine disruptors: a report of the USEPA-sponsored workshop. Environ Health Perspect 104(Suppl 4):715-740 (Pubitemid 26290301)
5. Commission E 1996 European workshop on the impact of endocrine disruptors on human health and wildlife. In: Environment and climate research programme DX. Brussels: European Commission
6. Damstra T, Barlow S, Bergman A, Kavlock RJ, van der Kraak G eds. 2002 Global assessment of the state-of-the-science of endocrine disruptors. Geneva: World Health Organization
7. Putzrath RM, Wilson JD 1999 Fundamentals of health risk assessment. Use, derivation, validity and limitations of safety indices. Risk Anal 19:231-247 (Pubitemid 29374649)
8. Borgert CJ, Mihaich EM, Quill TF, Marty MS, Levine SL, Becker RA 2011 Evaluation of EPA's Tier 1 endocrine screening battery and recommendations for improving the interpretation of screening results. Regul Toxicol Pharmacol 59:397-411
9. Kovacs WJ, Ojeda SR 2012 Textbook of endocrine physiology. 6th ed. Oxford: Oxford University Press
10. Charlton SJ 2009 Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. Br J Pharmacol 158:165-168
11. Jeyakumar M, Carlson KE, Gunther JR, Katzenellenbogen JA 2011 Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities. J Biol Chem 286:12971-12982
12. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS 2003 Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111:994-1006 (Pubitemid 36826881)
13. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs Jr DR, Lee DH, Shioda T, Soto AM, Vom Saal FS, Welshons WV, Zoeller RT, Myers JP 2012 Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev
14. Sheehan DM 2006 No-threshold dose-response curves for nongenotoxic chemicals: findings and applications for risk assessment. Environ Res 100:93-99 (Pubitemid 41767727)
15. Sheehan DM, Willingham E, Gaylor D, Bergeron JM, Crews D 1999 No threshold dose for estradiol-induced sex reversal of turtle embryos: howlittle is too much? Environ Health Perspect 107:155-159 (Pubitemid 29137728)
16. Melzer D, Osborne NJ, Henley WE, Cipelli R, Young A, Money C, McCormack P, Luben R, Khaw KT, Wareham NJ, Galloway TS 2012 Urinary bisphenol: a concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation
17. Murashima A, Miyagawa S, Ogino Y, Nishida-Fukuda H, Araki K, Matsumoto T, Kaneko T, Yoshinaga K, Yamamura K, Kurita T, Kato S, Moon AM, Yamada G 2011 Essential roles of androgen signaling in Wolffian duct stabilization and epididymal cell differentiation. Endocrinology 152:1640-1651
18. Renfree MB, Fenelon J, Wijiyanti G, Wilson JD, Shaw G 2009 Wolffian duct differentiation by physiological concentrations of androgen delivered systemically. Dev Biol 334:429-436
19. Welsh M, Saunders PT, Sharpe RM 2007 The critical time window for androgen-dependent development of the Wolffian duct in the rat. Endocrinology 148:3185-3195 (Pubitemid 46997011)
20. Jasuja R, Ulloor J, Yengo CM, Choong K, Istomin AY, Livesay DR, Jacobs DJ, Swerdloff RS, Miksovská J, Larsen RW, Bhasin S 2009 Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain. Mol Endocrinol 23:1231-1241
21. Arase S, Ishii K, Igarashi K, Aisaki K, Yoshio Y, Matsushima A, Shimohigashi Y, Arima K, Kanno J, Sugimura Y 2011 Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus. Biol Reprod 84:734-742
22. Whorwood CB, Sheppard MC, Stewart PM 1993 Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 132:2287-2292 (Pubitemid 23156873)
23. Veurink M, Koster M, Berg LT 2005 The history of DES, lessons to be learned. Pharm World Sci 27:139-143 (Pubitemid 41159959)
24. Walker DM, Gore AC 2011 Transgenerational neuroendocrine disruption of reproduction. Nat Rev Endocrinol 7:197-207
25. Gore AC, Patisaul HB 2010 Neuroendocrine disruption: historical roots, current progress, questions for the future. Front Neuroendocrinol 31:395-399
26. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D 2008 Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One 3:e3745
27. Ibhazehiebo K, Iwasaki T, Kimura-Kuroda J, Miyazaki W, Shimokawa N, Koibuchi N 2011 Disruption of thyroid hormone receptor-mediated transcription and thyroid hormone-induced Purkinje cell dendrite arborization by polybrominated diphenyl ethers. Environ Health Perspect 119:168-175
28. Miyazaki W, Iwasaki T, Takeshita A, Tohyama C, Koibuchi N 2008 Identification of the functional domain of thyroid hormone receptor responsible for polychlorinated biphenyl-mediated suppression of its action in vitro. Environ Health Perspect 116:1231-1236
29. McKinney JD, Waller CL 1998 Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. J Toxicol Environ Health B Crit Rev 1:27-58 (Pubitemid 128693555)
30. Shioda T, Chesnes J, Coser KR, Zou L, Hur J, Dean KL, Sonnenschein C, Soto AM, Isselbacher KJ 2006 Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci USA 103:12033-12038 (Pubitemid 44215806)
31. Ruhlen RL, Howdeshell KL, Mao J, Taylor JA, Bronson FH, Newbold RR, Welshons WV, vom Saal FS 2008 Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice. Environ Health Perspect 116:322-328 (Pubitemid 351395599)
32. vom Saal FS, Welshons WV 2006 Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100:50-76
33. Knudsen TB, Kavlock RJ, Daston GP, Stedman D, Hixon M, Kim JH 2011 Developmental toxicity testing for safety assessment: new approaches and technologies. Birth Defects Res B Dev Reprod Toxicol 92:413-420
34. De Wever B, Fuchs HW, Gaca M, Krul C, Mikulowski S, Poth A, Roggen EL, Vila MR 2012 Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation. Toxicol In Vitro
35. Borrell B 2010 Toxicology: the big test for bisphenol A. Nature 464:1122-1124
36. EPA U 2011 Endocrine disruptor screening program weight-of-evidence: evaluating results of EDSP Tier 1 screening to identify the need for Tier 2 testing. Washington, DC: Office of Chemical Safety and Pollution Prevention
37. Hood A, Hashmi R, Klaassen CD 1999 Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. Toxicol Appl Pharmacol 160:163-170 (Pubitemid 29498400)
38. Erickson MD 2001 PCB properties, uses, occurrence, and regulatory history. In: Robertson LW, Hansen LG, eds. PCBs: recent advances in environmental toxicology and health effects. Lexington, KY: The University Press of Kentucky; xii-xxx
39. Klaassen CD, Hood AM 2001 Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol Pathol 29:34-40 (Pubitemid 32127321)
40. Giera S, Bansal R, Ortiz-Toro TM, Taub DG, Zoeller RT 2011 Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development. Endocrinology 152:2909-2919
41. Amano I, Miyazaki W, Iwasaki T, Shimokawa N, Koibuchi N 2010 The effect of hydroxylated polychlorinated biphenyl (OH-PCB) on thyroid hormone receptor (TR)-mediated transcription through native-thyroid hormone response element (TRE). Ind Health 48:115-118
42. Langer P, Kocan A, Tajtáková M, Susienková K, Rádiková Z, Koska J, Ksinantová L, Imrich R, Hucková M, Drobná B, Gasperíková D, Trnovec T, Klimes I 2009 Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin). Thyroid Res 2:3
43. You SH, Gauger KJ, Bansal R, Zoeller RT 2006 4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells. Mol Cell Endocrinol 257-258:26-34 (Pubitemid 44292419)
44. Gilbert ME, Rovet J, Chen ZP, Koibuchi N 2011 Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology
45. Zoeller RT, Tyl RW, Tan SW 2007 Current and potential rodent screens and tests for thyroid toxicants. Crit Rev Toxicol 37:55-95
46. Lyche JL, Gutleb AC, Bergman A, Eriksen GS, Murk AJ, Ropstad E, Saunders M, Skaare JU 2009 Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev 12:225-249
47. Kamrin MA 2009 Phthalate risks, phthalate regulation, and public health: a review. J Toxicol Environ Health B Crit Rev 12:157-174
48. Gray Jr LE, Barlow NJ, Howdeshell KL, Ostby JS, Furr JR, Gray CL 2009 Transgenerational effects of Di (2-ethylhexyl) phthalate in the male CRL:CD(SD) rat: added value of assessing multiple offspring per litter. Toxicol Sci 110:411-425
49. Foster PM 2006 Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl 29:140-147; discussion 181-145
50. Noriega NC, Howdeshell KL, Furr J, Lambright CR, Wilson VS, Gray Jr LE 2009 Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats. Toxicol Sci 111:163-178
51. Kurata Y, Makinodan F, Shimamura N, Katoh M 2012 Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats. J Toxicol Sci 37:33-49
52. Rajapakse N, Silva E, Kortenkamp A 2002 Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 110:917-921
53. Alonso-Magdalena P, Quesada I, Nadal A 2011 Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 7:346-353
54. Watson CS, Jeng YJ, Kochukov MY 2010 Nongenomic signaling pathways of estrogen toxicity. Toxicol Sci 115:1-11
55. Newbold RR, Jefferson WN, Padilla-Banks E 2009 Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117:879-885
56. Welshons WV, Nagel SC, vom Saal FS 2006 Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56-S69 (Pubitemid 43778691)
57. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquié M, Gauthier BR, Nef S, Stefani E, Nadal A 2008 A pancreatic insulin content regulation by the estrogen receptor ERα. PLoS One 3:e2069
58. Soriano S, Alonso-Magdalena P, García-Areválo M, Novials A, Muhammed SJ, Salehi A, Gustafsson JA, Quesada I, Nadal A 2012 A rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β. PLoS One 7:e31109
59. Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, Quesada I, Nadal A 2010 Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 118:1243-1250
60. Jenkins S, Wang J, Eltoum I, Desmond R, Lamartiniere CA 2011 Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect 119:1604-1609
61. LaPensee EW, Ben-Jonathan N 2010 Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. Endocr Relat Cancer 17:R91-R107
62. Soto AM, Vandenberg LN, Maffini MV, Sonnenschein C 2008 Does breast cancer start in the womb? Basic Clin Pharmacol 102:125-133 (Pubitemid 351143422)
63. Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM 2007 Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol 23:383-390 (Pubitemid 46602926)
64. Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH, Muñoz-de-Toro M 2007 Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 115:80-86 (Pubitemid 46050286)
65. Betancourt AM, Eltoum IA, Desmond RA, Russo J, Lamartiniere CA 2010 In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect 118:1614-1619
66. Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J, Lamartiniere CA 2009 Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect 117:910-915
67. Lake JL, McKinney R, Lake CA, Osterman FA, Heltshe J 1995 Comparisons of patterns of polychlorinated biphenyl congeners in water, sediment, and indigenous organisms from New Bedford Harbor, Massachusetts. Arch Environ Contam Toxicol 29:207-220
68. McFarland VA, Clarke JU 1989 Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 81:225-239 (Pubitemid 19156889)
69. Quinn CL, Wania F, Czub G, Breivik K 2011 Investigating intergenerational differences in human PCB exposure due to variable emissions and reproductive behaviors. Environ Health Perspect 119:641-646
70. Hansen LG 1998 Stepping backward to improve assessment of PCB congener toxicities. Environ Health Perspect 106(Suppl 1):171-189 (Pubitemid 28196043)
71. Ma R, Sassoon DA 2006 PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect 114:898-904 (Pubitemid 43871740)
72. Carpenter DO 2006 Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health 21:1-23
73. Welshons WV, Jordan VC 1987 Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol 23:1935-1939 (Pubitemid 18013337)